Clinical trial Recruiting at 1 site Phase 2 Interventional Ages 2 to 18

Intravesical aminophylline to aid ureteroscopic access in children with distal ureteral stones

Official title: Intravesical Aminophylline to Facilitate Semi-Rigid Ureteroscopic Access in Children With Lower Ureteral Stones: A Prospective Randomized Double-Blind Placebo-Controlled Trial

Run by Beni-Suef University · NCT07617896 · Data updated 2026-11-12

This study tests whether putting aminophylline in the bladder helps some kids get a semi-rigid ureteroscope to pass into the ureter during treatment for distal ureteral stones.

More Ureteral Calculi trials

Quick facts

PhasePhase 2
Study typeInterventional
Ages2 Years to 18 Years
SexAll
Enrollment60 (estimated)
SponsorBeni-Suef University
Academic / other
Locations1 site (Banī Suwayf, Beni Suweif Governorate)
StatusRecruiting
StartedMay 9, 2026
Main results expectedApril 2027
Study endsMay 2027
Registry record updatedJune 1, 2026
Trial IDNCT07617896 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children aged 2–18 years with a single distal ureteral stone (5–15 mm) scheduled for semi-rigid ureteroscopy and who fail the initial gentle ureteroscope passage during surgery.

Probably not a fit

Children who pass the initial gentle attempt, or those not experiencing access failure, will not receive any additional benefit from the randomization and will continue standard care.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a single-center, randomized, double-blind trial in children undergoing semi-rigid ureteroscopy for distal ureteral stones. If the initial gentle attempt to pass the ureteroscope fails, participants are randomized to receive intravesical aminophylline or saline placebo for about five minutes before a second access attempt. The primary outcome is successful same-session passage of the ureteroscope without balloon dilation or additional invasive steps. The study aims to determine whether aminophylline improves access and potentially reduces the need for stenting or further maneuvers. Eligible children are between 2 and 18 years old with a single distal stone 5–15 mm, undergoing planned definitive treatment at Beni-Suef University Hospital.

Why it matters

Potential benefit: If successful, aminophylline could increase the chance of accessing the ureter in a single session, possibly reducing additional procedures and anesthesia exposure.

How similar studies have gone: Prior approaches using intravesical agents to facilitate ureteroscopic access have limited data; this trial explores a novel intraoperative strategy in pediatric patients.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Children older than 2 years and younger than 18 years.
* Single unilateral lower/distal ureteral stone confirmed by low-dose non-contrast computed tomography according to local policy.
* Stone size 5 to 15 mm.
* Candidate for definitive treatment by semi-rigid ureteroscopy.
* Sterile urine culture before surgery, or previously positive urine culture that has been properly treated before intervention.
* Intraoperative failed initial gentle negotiation of the ureteric orifice/intramural ureter according to the study definition.
* Written informed consent from the parent or legal guardian, with child assent when appropriate.

Exclusion Criteria:

* Known hypersensitivity to aminophylline, theophylline, or ethylenediamine.
* Use of oral or intravenous aminophylline or theophylline within the previous 24 hours.
* Pre-existing ipsilateral JJ ureteral stent.
* Stone peeping at the ureteric orifice.
* Congenital or acquired abnormality that may affect distal ureteric access, such as ureterocele, obstructive megaureter, distal ureteric stricture, previous ureteric reimplantation, or previous ipsilateral ureteral reconstruction.
* Known bladder dysfunction or conditions likely to affect normal bladder capacity.
* Multiple ipsilateral ureteral stones or associated renal stones requiring flexible ureteroscopy or a ureteral access sheath strategy.
* Febrile urinary tract infection, pyonephrosis, sepsis, or any case requiring urgent decompression instead of definitive ureteroscopy.
* Cardiac disease, arrhythmia, uncontrolled hypertension, hyperthyroidism, epilepsy or seizure disorder, or significant hepatic impairment.
* Inability to complete follow-up.

Where it's running

  • Department of Urology- Beni-Suef University Hospitals
    Banī Suwayf, Beni Suweif Governorate, Egypt
    Recruiting

Study contacts

  • Principal investigator: Hany F Badawy, MD — Faculty of medicine BeniSuef University
  • Study coordinator: Hany F Badawy, Md
  • Email: HANYFATHY86@GMAIL.COM
  • Phone: +201149525028

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.